The Pharmaceutical Journal
Vol 276 No 7398 p516
29 April 2006

Society summary

Death of Charter gold medallist John Stenlake

John Stenlake, CBE, FRPharmS, a holder of the Royal Pharmaceutical Society's Charter gold medal, has died at the age of 86.

Professor Stenlake’s medal, awarded in 1990, recognised, among other things, his contribution to the design and synthesis of atracurium besylate — the first short acting and readily reversible skeletal muscle relaxant for use in surgery. The drug was developed by a research team led by Professor Stenlake in the pharmacy department of Strathclyde University in collaboration with the Wellcome Foundation.

Professor Stenlake also received the Society’s Harrison memorial medal in 1974.


Deaths, p519